OpenOpportunity GG-RFA-AI-27-005New
Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
The purpose of this notice of funding opportunity (NOFO) is to support a Clinical Research Network (CRN) on Antimicrobial Resistance (AMR). The program aims to design, implement, and manage clinical research that addresses pivotal clinical questions related to AMR through a coordinated and integrated CRN. The CRN will comprise four centers: the Scientific Leadership Center (SLC), the Clinical Operations Center (COC), the Laboratory Center (LC), and the Statistics and Data Coordination Center (SDCC).
From Grants.gov — open and forecasted opportunities (grants.gov). First seen Oct 10, 2026.
Details
- Agency
- National Institutes of HealthFind in source ↗
- Closes
- Nov 10, 2026Find in source ↗
- Total program funding
- $18,000,000.00Find in source ↗
- Posted
- Sep 1, 2026Find in source ↗
- Opportunity number
- RFA-AI-27-005Find in source ↗
- Assistance listing (ALN)
- 93.855Find in source ↗
- Eligible applicants
- Native American tribal organizations (other than Federally recognized tribal governments); Public and State controlled institutions of higher education; Others (see text field entitled "Additional Information on Eligibility" for clarification); Public housing authorities/Indian housing authorities; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; State governments; Small businesses; City or township governments; Private institutions of higher education; County governments; Special district governments; Independent school districts; For profit organizations other than small businesses; Native American tribal governments (Federally recognized)Find in source ↗
- Eligibility notes
- Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed. NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. See NIH Grants Policy Statement 16.8 Collaborative International Research Awards.Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.Find in source ↗
- Category
- HealthFind in source ↗
- Funding type
- Cooperative AgreementFind in source ↗
History
No changes since GrantScout first read this opportunity on Oct 10, 2026.
Sign in to keep notes on this opportunity, private or shared with your team.